Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited (SBHMY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SBHMY · as of Jun 8, 2026
Key Statistics
Explore Sino Biopharmaceutical Limited Data
sbhmy stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
sbhmy competitorsSBHMY
ALPMF
ALPMY
BMXXY
GNMSF
IVBXFStock Performance
Full HistoryAbout Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited operates as a prominent research and development-centric pharmaceutical conglomerate in the People's Republic of China, functioning as an investment holding company. Its…
what is sino biopharmaceutical limited · sbhmy stock overview · sino biopharmaceutical limited company profile · who is sino biopharmaceutical limited ceo · sbhmy OTC · sino biopharmaceutical limited headquarters · sino biopharmaceutical limited business segments
About Stock Overview & Key Data
Sino Biopharmaceutical Limited (SBHMY) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 5, 2017. As of the latest trading session, SBHMY stock price is $12.98, with a market capitalization of $11.6B. The stock has returned +36.92% over the past 12 months and -28.76% year-to-date.
In fiscal year 2025, Sino Biopharmaceutical Limited reported revenue of $31.0B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Sino Biopharmaceutical Limited (SBHMY) stock price is $12.98. The stock is traded on OTC under the ticker symbol SBHMY. The 52-week range is $9.48 – $20.16.